UA100018C2 - Соединение-иммуномодулятор для лечения, профилактики, ингибирования или уменьшения проявлений аллергической болезни или ее эффектов - Google Patents

Соединение-иммуномодулятор для лечения, профилактики, ингибирования или уменьшения проявлений аллергической болезни или ее эффектов

Info

Publication number
UA100018C2
UA100018C2 UAA200912624A UAA200912624A UA100018C2 UA 100018 C2 UA100018 C2 UA 100018C2 UA A200912624 A UAA200912624 A UA A200912624A UA A200912624 A UAA200912624 A UA A200912624A UA 100018 C2 UA100018 C2 UA 100018C2
Authority
UA
Ukraine
Prior art keywords
inhibiting
treating
preventing
effects
allergic disease
Prior art date
Application number
UAA200912624A
Other languages
English (en)
Ukrainian (uk)
Inventor
Александр А. Колобов
Андрей С. Симбирцев
Original Assignee
Сайклон Фармасютикалс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сайклон Фармасютикалс, Инк. filed Critical Сайклон Фармасютикалс, Инк.
Publication of UA100018C2 publication Critical patent/UA100018C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Соединение - иммуномодулятор формулы А, или его фармацевтически приемлемая соль(А),где n представляет собой 2, R представляет собой водород, ацил, алкил, и X представляет собой L-триптофан или D-триптофан, для применения для лечения, профилактики, ингибирования или уменьшения проявлений аллергической болезни или ее эффектов в субъекта.
UAA200912624A 2007-05-17 2008-05-13 Соединение-иммуномодулятор для лечения, профилактики, ингибирования или уменьшения проявлений аллергической болезни или ее эффектов UA100018C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2007118237/14A RU2007118237A (ru) 2007-05-17 2007-05-17 Способ лечения аллергических заболеваний

Publications (1)

Publication Number Publication Date
UA100018C2 true UA100018C2 (ru) 2012-11-12

Family

ID=40122024

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200912624A UA100018C2 (ru) 2007-05-17 2008-05-13 Соединение-иммуномодулятор для лечения, профилактики, ингибирования или уменьшения проявлений аллергической болезни или ее эффектов

Country Status (14)

Country Link
US (1) US20100204295A1 (ru)
EP (1) EP2164507B1 (ru)
JP (1) JP2010527354A (ru)
KR (1) KR20100022044A (ru)
CN (1) CN101678069A (ru)
AU (1) AU2008253667A1 (ru)
BR (1) BRPI0811572A2 (ru)
CA (1) CA2684046A1 (ru)
IL (1) IL202114A0 (ru)
MX (1) MX2009012297A (ru)
NZ (1) NZ581748A (ru)
RU (1) RU2007118237A (ru)
UA (1) UA100018C2 (ru)
WO (1) WO2008143824A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090119897A (ko) 2007-02-13 2009-11-20 사이클론 파아머슈티컬 인코오퍼레이티드 점막의 질환으로 인한 조직 악화, 상처 또는 손상을 치료 또는 예방하는 방법
RU2635968C1 (ru) * 2016-11-17 2017-11-17 Аллан Герович Бениашвили Способ лечения и профилактики состояний аллергического спектра
KR102633086B1 (ko) * 2018-11-12 2024-02-05 씨제이제일제당 주식회사 N-아세틸-l-트립토판을 유효성분으로 포함하는 젖소용 사료첨가제
KR102376756B1 (ko) * 2019-05-24 2022-03-21 주식회사 스템디알 N-아실-아미노산을 유효성분으로 포함하는 천식, 비염 또는 결막염의 예방 또는 치료용 조성물
US20220233502A1 (en) * 2019-05-24 2022-07-28 Stemdr Inc. Composition for preventing or treating asthma, rhinitis or conjunctivitis, comprising n-acyl amino acid as active ingredient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
SU1544438A1 (ru) 1988-04-04 1990-02-23 Научно-исследовательский институт онкологии им.проф.Н.Н.Петрова Способ плазмосорбции
US5032593A (en) * 1988-07-01 1991-07-16 Marion Merrell Dow Inc. Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US7173013B2 (en) * 2001-06-08 2007-02-06 Sciclone Pharmaceuticals, Inc. Treatment of tuberculosis using immunomodulator compounds
WO2005112639A2 (en) * 2004-05-14 2005-12-01 Sciclone Pharmaceuticals, Inc. Treatment or prevention of respiratory viral infections with immunomodulator compounds

Also Published As

Publication number Publication date
BRPI0811572A2 (pt) 2015-07-21
KR20100022044A (ko) 2010-02-26
NZ581748A (en) 2012-03-30
IL202114A0 (en) 2010-06-16
AU2008253667A1 (en) 2008-11-27
MX2009012297A (es) 2010-02-17
CA2684046A1 (en) 2008-11-27
WO2008143824A1 (en) 2008-11-27
CN101678069A (zh) 2010-03-24
JP2010527354A (ja) 2010-08-12
RU2007118237A (ru) 2008-11-27
US20100204295A1 (en) 2010-08-12
EP2164507B1 (en) 2012-07-11
EP2164507A4 (en) 2011-01-05
EP2164507A1 (en) 2010-03-24

Similar Documents

Publication Publication Date Title
PH12013501288A1 (en) Peptide deformylase inhibitors
SG179418A1 (en) Inhibitors of the hedgehog pathway
MX2009006756A (es) Derivados de 1-amino-metil-l-fenil-ciclohexano como inhibidores de dpp-iv.
UA96777C2 (ru) Фенилпропионамидные соединения и их применение как опиоидных агонистов
MX2007004699A (es) Derivados de indol y bencimidazol.
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
GEP20156267B (en) 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
IN2012DN01325A (ru)
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
SG149033A1 (en) Heterocyclic inhibitors of mek and methods of use thereof
SI2298768T1 (en) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyridoS2,3-dCpyrimidine derivatives and related compounds for the treatment of cancer
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
MX2009003157A (es) Pirazoliltienopiridinas terapeuticas.
TN2009000049A1 (en) A pyrrolopyrazin as syk-kinase inhibitor
TW200833675A (en) Nicotinamide derivatives
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
GEP20166443B (en) Heterocyclic compound and use thereof
GB0413087D0 (en) Therapeutic compounds
MA33721B1 (fr) Derives sulfonamides heterocycliques utilises comme inhibiteurs de mek
MA32240B1 (fr) Inhibiteurs de désacétylases b à base d'hydroxamate
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
MX2011008910A (es) Derivados de azol sustituidos, composicion farmaceutica que comprende los derivados, y uso de los derivados para tratar enfermeda de parkinson.
UA100018C2 (ru) Соединение-иммуномодулятор для лечения, профилактики, ингибирования или уменьшения проявлений аллергической болезни или ее эффектов